Horizontal transmission of candida albicans and evidence of a vaccine response in mice colonized with the fungus

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Cutler, Jim E ^a,b   Corti, Miriam ^b   Lambert, Patrick ^b   Ferris, Michael ^a   Xin, Hong ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Research Institute for Children at Children's Hospital New Orleans   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS VACCINE; DRINKING WATER; FLUCONAZOLE; FRUCTOSE BISPHOSPHATE ALDOLASE; FUNGUS ANTIBODY; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; ANTIINFECTIVE AGENT; FUNGUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BODY MASS; CANDIDA ALBICANS; CONTROLLED STUDY; FECES MICROFLORA; FEMALE; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS TRANSMISSION; GASTROINTESTINAL TRACT; HOST RESISTANCE; INVASIVE CANDIDIASIS; MOUSE; NONHUMAN; ANIMAL; BACTERIAL COUNT; BLOOD; C57BL MOUSE; CANDIDIASIS; DISEASE TRANSMISSION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; PILOT STUDY; VACCINATION;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; FUNGI; MUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, FUNGAL; ANTIBODY FORMATION; CANDIDA ALBICANS; CANDIDIASIS; COLONY COUNT, MICROBIAL; DISEASE TRANSMISSION, INFECTIOUS; FUNGAL VACCINES; GASTROINTESTINAL TRACT; HUMANS; MICE; MICE, INBRED C57BL; PILOT PROJECTS; VACCINATION;

EID: 79960447072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022030     Document Type: Article

References (52)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a propspective nationwide surveillance study. Clin Infect Dis 39: 309-317.
2. Hsu FC, Lin PC, Chi CY, Ho MW, Wang JH, (2009) Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery. J Microbiol Immunol Infect 42: 378-384.
3. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, et al. (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48: 1695-1703.
4. Xin H, Dziadek S, Bundle DR, Cutler JE, (2008) Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci USA 105: 13526-13531.
5. Cutler JE, Deepe GS Jr, Klein BS, (2007) Advances in combating fungal diseases: Vaccines on the threshold. Nat Rev Microbiol 5: 13-28.
6. Spellberg B, Ibrahim AS, Lin L, Avanesian V, Fu Y, et al. (2008) Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J Infect Dis 197: 967-971.
7. Conti HR, Gaffen SL, (2010) Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect 12: 518-527.
8. van de Veerdonk FL, Kullberg BJ, Netea MG, (2010) Pathogenesis of invasive candidiasis. Curr Opin Crit Care 16: 453-459.
9. Han Y, Cutler JE, (1995) Antibody response that protects against disseminated candidiasis. Infect Immun 63: 2714-2719.
10. Torosantucci A, Chiani P, Bromuro C, De Bernardis F, Palma AS, et al. (2009) Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 4: e5392.
11. Karwa R, Wargo KA, (2009) Efungumab: a novel agent in the treatment of invasive candidiasis. Ann Pharmacother 43: 1818-1823.
12. Mochon AB, Cutler JE, (2005) Is a vaccine needed against Candida albicans? Med Mycol 43: 97-115.
13. Han Y, Kanbe T, Cherniak R, Cutler JE, (1997) Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun 65: 4100-4107.
14. Ponton J, Omaetxebarria MJ, Elguezabal N, Alvarez M, Moragues MD, (2001) Immunoreactivity of the fungal cell wall. Med Mycol 39: 101-110.
15. Klis FM, De Groot P, Hellingwerf K, (2001) Molecular organization of the cell wall of Candida albicans. Medical Mycology 39: 1-8.
16. Heráez ML, Ximénez-Embún P, Martinez-Gomariz M, Guitiérrez-Blázquez MD, Nombela C, Gil C, (2010) Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach. J Proteomics 73: 1404-1409.
17. Pitarch A, Sanchez M, Nombela C, Gil C, (2002) Sequential fractionation and two-dimensional gel analysis unravels the complexity of the dimorphic fungus Candida albicans cell wall proteome. Mol Cell Proteomics 1: 967-982.
18. Pitarch A, Jimenez A, Nombela C, Gil C, (2006) Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteonic and bioinformatic analyses. Mol Cell Proteomics 5: 79-96.
19. Nitz M, Ling C-C, Otter A, Cutler JE, Bundle DR, (2002) The unique solution structure and immunochemistry of the Candida albicans β-1,2-mannopyranan cell wall antigens. J Biol Chem 277: 3440-3446.
20. Goins T, Cutler JE, (2000) Relative abundance of oligosaccharides in Candida species as determined by fluorophore-assisted carbohydrate electrophoresis. J Clin Microbiol 38: 2862-2869.
21. Kobayashi H, Oyamada H, Iwadate N, Suzuki H, Mitobe H, et al. (1998) Structural and immunochemical characterization of beta-1,2-linked mannobiosyl phosphate residue in the cell wall mannan of Candida glabrata. Arch Microbiol 169: 188-194.
22. Shibata N, Kobayashi H, Okawa Y, Suzuki S, (2003) Existence of novel β-1,2 linkage-containing side chain in the mannan of Candida lusitaniae, antigenically related to Candida albicans. Eur J Biochem 270: 2565-2575.
23. Kobayashi H, Oyamada H, Matsuda K, Shibata N, Suzuki S, (2003) Distribution of antigenic oligomannosyl side chains in the cell wall mannans of several strains of Candida tropicalis. Arch Microbiol 180: 76-80.
24. Wrobel L, Whittington JK, Puhol C, Oh SH, Ruiz MO, et al. (2008) Molecular phylogenetic analysis of a geographically and temporally matched set of Candida albicans isolates from humans and nonmigratory wildlife in central Illinois. Eukaryot Cell 7: 1475-1486.
25. Mellado E, Cuenca-Estrella M, Regadera J, González M, Díaz-Guerra TM, et al. (2000) Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice. Diagn Microbiol Infect Dis 38: 21-28.
26. Samonis G, Anastassiadou H, Tselentis Y, Bodey GP, (1994) Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans. Antimicrob Agents Chemother 38: 602-603.
27. Ekenna O, Sherertz RJ, (1987) Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice. Infect Immun 55: 1558-1563.
28. White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, et al. (2007) Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog 3: e184.
29. Vargas SL, Patrick CC, Ayers GD, Hughes WT, (1993) Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model. Infect Immun 61: 619-626.
30. Domer JE, Hector RF, (1987) Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans. Antimicrob Agents Chemother 31: 691.
31. Tansho S, Abe S, Ishibashi H, Mitsuya M, et al. (2004) Production of anti-Candida antibodies in mice with gut colonization of Candida albicans. Mediators Inflam 13: 189-193.
32. Koh AY, Köhler JR, Coggshall KT, van Rooijen N, Pier GB, (2008) Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 4: e35.
33. Kanbe T, Han Y, Redgrave B, Riesselman MH, Cutler JE, (1993) Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect Immun 61: 2578-2584.
34. Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, et al. (2006) Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typin. J Clin Microbiol 44: 3647-3658.
35. Odds FC, (1988) Candida and candidosis. London Bailliere Tindall.
36. Artwohl JE, Savage DC, (1979) Determinants in microbial colonization of the murine gastrointestinal tract: pH, temperature, and energy-yielding metabolism of Torulopsis pintolopesii. Appl Environ Microbiol 37: 697-703.
37. Savage DC, Dubos RJ, (1967) Localization of indigenous yeast in the murine stomach. J Bacteriol 94: 1811-1816.
38. Savage DC, (1977) Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 31: 107-133.
39. Suegara N, Siegel JE, Savage DC, (1979) Ecological determinants in microbial colonization of the murine gastrointestinal tract: adherence of Torulopsis pintolopesii to epithelial surfaces. Infect Immun 25: 139-145.
40. Field LH, Pope LM, Cole GT, Guentzel MN, Berry LJ, (1981) Persistance and spread of Candida albicans after intragastric inoculation of infant mice. Infect Immun 31: 783-791.
41. Cliff PR, Sandoe JA, Heritage J, Barton RC, (2008) Use of multilocus sequence typing for the investigatioin of colonisation by Candida albicans in intensive care unit patients. J Hosp Infect 69: 24-32.
42. Bliss JM, Basavegowda KP, Watson WJ, Sheikh AU, Ryan RM, (2008) Vertical and horizontal transmission of Candida albicans in very low birth weight infants using DNA fingerprinting techniques. Pediatr Infect Dis J 27: 231-235.
43. Lupetti A, Tavanti A, Davini P, (2002) Horizontal transmission of Candida parasilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 40: 2363-2369.
44. Xin H, Granger BL, Dziadek S, Bundle DR, Cutler JE, (2007) Antigen-pulsed dendritic cells used for identification of carrier peptides and eventual glycopeptide conjugate vaccines against candidiasis. ASM Proc (Abst).
45. Hazen KC, Hazen BW, (1987) A polystyrene microsphere assay for detecting surface hydrophobicity variations within Candida albicans populations. J Microbiol Methods 6: 289-299.
46. Xin H, Cutler JE, (2006) Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis. Infect Immun 74: 4310-4321.
47. Bougnoux ME, Morand S, d'Enfert C, (2002) Usefulness of multilocus sequence typing for characterization of clilnical isolates of Candida albicans. J Clin Microbiol 40: 1290-1297.
48. Bougnoux ME, Diogo D, Francois N, Sendid B, Veirmeire S, et al. (2006) Multilocus sequence typing reveals intrfamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract. J Clin Microbiol 44: 1810-1820.
49. Tavanti A, Gow NAR, Senesi S, Maiden MCJ, Odds FC, (2003) Optimization and validation of multilocus sequence typing for Candida albicans. J Clin Microbiol 41: 3765-3776.
50. Tewari RP, Sharma DK, Mathur A, (1978) Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of histoplasma capsulatum. J Infect Dis 138: 605-613.
51. Han Y, Ulrich MA, Cutler JE, (1999) Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J Infect Dis 179: 1477-1484.
52. Kanbe T, Cutler JE, (1994) Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans. Infect Immun 62: 1662-1668.